<\/p>\n
NEW FILINGS<\/strong> Company: South Plains Financial, Inc. Company: Cortexyme, Inc. Company: Mayville Engineering Company, Inc. Company: Applied Therapeutics, Inc. Company: NextCure, Inc. Company: Parsons Corporation Company: Axcella Health Inc. Company: Uber Technologies, Inc. Company: Red River Bancshares, Inc. Company: So-Young International Inc. Company: Trevi Therapeutics, Inc. Company: TransMedics Group, Inc. Company: SciPlay Corporation TERMS ADDED<\/strong><\/p>\n Company: Palomar Holdings, Inc. Company: Turning Point Therapeutics, Inc. Company: Zoom Video Communications, Inc. Company: Pinterest, Inc. Company: HOOKIPA Pharma Inc. Company: Greenlane Holdings, Inc. Company: Brigham Minerals, Inc.
\nCompany: Milestone Pharmaceuticals Inc.
\nSymbol: MIST
\nDescription: They are a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, Cowen, Piper Jaffray
\nFiled: 4-12-19
\nListed Cash Raise: $86.25m<\/p>\n
\nSymbol: SPFI
\nDescription: They are a bank holding company headquartered in Lubbock, Texas, and our wholly-owned subsidiary, City Bank, is one of the largest independent banks in West Texas.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Keefe Bruyette & Woods, Sandler O’ Neill
\nFiled: 4-12-19
\nListed Cash Raise: $50m<\/p>\n
\nSymbol: CRTX
\nDescription: They are a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what we believe to be a key underlying cause of Alzheimer\u2019s and other degenerative diseases.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): BofA Merrill Lynch, Credit Suisse
\nCo-Manager: Canaccord Genuity, JMP Securities
\nFiled: 4-12-19
\nListed Cash Raise: $86.25m<\/p>\n
\nSymbol: MEC
\nDescription: MEC is a leading U.S.-based value-added manufacturing partner that provides a broad range of prototyping and tooling, production fabrication, coating, assembly and aftermarket components.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Baird, Citigroup, Jefferies
\nCo-Manager(s): UBS Investment Bank, William Blair
\nFiled: 4-12-19
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: APLT
\nDescription: They are a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Citigroup, Cowen, UBS Investment Bank
\nCo-Manager: Baird
\nFiled: 4-12-19
\nListed Cash Raise: $86.25m<\/p>\n
\nSymbol: NXTC
\nDescription: They are a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, BofA Merrill Lynch, Piper Jaffray
\nFiled: 4-12-19
\nListed Cash Raise: $86.25m<\/p>\n
\nSymbol: PSN
\nDescription: They are a leading provider of technology-driven solutions in the defense, intelligence and critical infrastructure markets.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, BofA Merrill Lynch, Morgan Stanley
\nCo-Manager(s): Jefferies, Wells Fargo, Cowen, SunTrust Robinson, MUFG, Scotiabank
\nFiled: 4-12-19
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: AXLA
\nDescription: They are a biotechnology company pioneering the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers and patients who have limited options.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, JP Morgan, SVB Leerink
\nFiled: 4-12-19
\nListed Cash Raise: $86.25m<\/p>\n
\nSymbol: UBER
\nDescription: Their mission is to ignite opportunity by setting the world in motion. They revolutionized personal mobility with Ridesharing, and they are leveraging their platform to redefine the massive meal delivery and logistics industries.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, Goldman Sachs, BofA Merrill Lynch, Barclays, Citigroup, Allen & Co.
\nCo-Manager(s): RBC Capital, SunTrust Robinson Humphrey, Deutsche Bank, HSBC, SMBC, Mizuho Securities, Needham, Loop Capital Markets, Siebert Cisneros Shank & Co., Academy Securities, BTIG, Canaccord Genuity, CastleOak Securities, Cowen, Evercore ISI, JMP Securities, Macquarie Capital, Mischler Financial, Oppenheimer & Co., Raymond James, William Blair, The Williams Capital Group, TPG Capital BD
\nFiled: 4-11-19
\nListed Cash Raise: $1bn<\/p>\n
\nSymbol: RRBI
\nDescription: They are a community banking franchise concentrated in Louisiana.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): FIG Partners, Stephens Inc.
\nFiled: 4-10-19
\nListed Cash Raise: $30m<\/p>\n
\nSymbol: SY
\nDescription: Their mission is to bring beauty and health to everyone.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Deutsche Bank, CICC
\nFiled: 4-8-19
\nListed Cash Raise: $150m<\/p>\n
\nSymbol: TRVI
\nDescription: They are a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): SVB Leerink, Stifel, BMO Capital
\nCo-Manager(s): Needham
\nFiled: 4-5-19
\nListed Cash Raise: $86.25m<\/p>\n
\nSymbol: TMDX
\nDescription: They are a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, JP Morgan
\nCo-Manager(s); Cowen, Canaccord Genuity
\nFiled: 4-5-19
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: SCPL
\nDescription: They are a leading developer and publisher of digital games on mobile and web platforms.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): BofA Merrill Lynch, JP Morgan, Deutsche Bank, Goldman Sachs, Morgan Stanley, Macquarie Capital, RBC Capital
\nCo-Manager(s): Stifel, Wedbush Securities
\nFiled: 4-5-19
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: PLMR
\nDescription: They are a rapidly growing and profitable company focused on the provision of specialty property insurance.
\nShares: 5.625 million
\nPrice Range: $15.00-$17.00
\nTrade Date: 4\/17
\nUnderwriter(s): Barclays, JP Morgan, Keefe Bruyette & Woods
\nCo-Manager(s): Evercore ISI, William Blair, Sandler O’ Neill, SunTrust Robinson Humphrey
\nTerms Added: 4-8-19<\/p>\n
\nSymbol: TPTX
\nDescription: They are a clinical-stage biopharmaceutical company designing and developing novel small molecule, targeted oncology therapies to address key limitations of existing therapies and improve the lives of patients.
\nShares: 7.35 million
\nPrice Range: $16.00-$18.00
\nTrade Date: 4\/18
\nUnderwriter(s): Goldman Sachs & Co. LLC, SVB Leerink, Wells Fargo Securities
\nCo-Manager(s): Canaccord Genuity
\nTerms Added: 4-8-19<\/p>\n
\nSymbol: ZM
\nDescription: They provide a video-first communications platform that delivers happiness and fundamentally changes how people interact.
\nShares: 20.87 million
\nPrice Range: $28.00-$32.00
\nTrade Date: 4\/18
\nUnderwriter(s): Morgan Stanley, JP Morgan, Goldman Sachs, Credit Suisse, BofA Merrill Lynch, RBC Capital, Wells Fargo
\nCo-Manager(s): JMP Securities, Keybanc Capital, Piper Jaffray, Stifel, William Blair
\nTerms Added: 4-8-19<\/p>\n
\nSymbol: PINS
\nDescription: Pinterest is where more than 250 million people around the world go to get inspiration for their lives.
\nShares: 75 million
\nPrice Range: $15.00-$17.00
\nTrade Date: 4\/18
\nUnderwriter(s): Goldman Sachs & Co., J.P. Morgan, Allen & Company, BofA Merrill Lynch, Barclays, Citigroup, Credit Suisse, Deutsche Bank Securities, RBC Capital Markets
\nCo-Manager(s):Baird, UBS, Wells Fargo
\nTerms Added: 4-8-19<\/p>\n
\nSymbol: HOOK
\nDescription: They are a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on our proprietary arenavirus platform that is designed to reprogram the body’s immune system.
\nShares: 6.67 million
\nPrice Range: $14.00-$16.00
\nTrade Date: 4\/18
\nUnderwriter(s): BofA Merrill Lynch, SVB Leerink , RBC Capital
\nCo-Manager(s): Kempen
\nTerms Added: 4-8-19<\/p>\n
\nSymbol: GNLN
\nDescription: They are a leading distributor of premium vaporization products and consumption accessories in the United States and have a growing presence in Canada.
\nShares: 5.33 million
\nPrice Range: $14.00-$16.00
\nTrade Date: 4\/18
\nUnderwriter(s): Cowen, Canaccord Genuity
\nCo-Manager(s): Ladenburg Thalmann, Roth Capital, Northland Capital
\nTerms Added: 4-8-19<\/p>\n
\nSymbol: MNRL
\nDescription: They formed their company in 2012 to acquire and actively manage a portfolio of mineral and royalty interests in the core of what they view as the most active, highly economic, liquids-rich resource basins across the continental United States.
\nShares: 13.5 million
\nPrice Range: $15.00-$18.00
\nTrade Date: 4\/18
\nUnderwriter(s): Credit Suisse, Goldman Sachs, Barclays, RBC Capital, UBS Investment, Wells Fargo Securities
\nCo-Manager(s): Raymond James, Seaport Global, Simmons Energy, Tudor Pickering & Holt
\nTerms Added: 4-9-19<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-7693","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/7693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=7693"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/7693\/revisions"}],"predecessor-version":[{"id":7708,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/7693\/revisions\/7708"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=7693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=7693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=7693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}